SCHEMBL1634743

SCHEMBL1634743

NS(=O)(=O)c1ccc(Nc2ncc3cccc(OC4CCCC4)c3n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 1/20 0.55
JAK2 O60674 2/20 0.52
JAK1 P23458 2/20 0.52
TYK2 P29597 2/20 0.52
JAK3 P52333 2/20 0.52
CDK2 P24941 7/20 0.48
KDR P35968 1/20 0.48
IKBKB O14920 3/20 0.47
SYK P43405 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA4 P22748 2/20 0.47
CA9 Q16790 2/20 0.47
CDK1 P06493 5/20 0.47
CDK9 P50750 2/20 0.47
CCNT1 O60563 1/20 0.47
CCNB1 P14635 1/20 0.47
CDK7 P50613 1/20 0.47
CCNH P51946 1/20 0.47
CCNE1 P24864 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633545 0.91 JAK2 (0.65) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1633530 0.89 JAK2 (0.58) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1632062 0.88 JAK2 (0.52) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1632939 0.88 JAK2 (0.51) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1634722 0.87 JAK2 (0.54) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1632781 0.87 JAK2 (0.58) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1632785 0.87 JAK2 (0.58) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1634422 0.87 JAK2 (0.58) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1632811 0.86 JAK2 (0.54) TNIKJAK2JAK1TYK2JAK3
SCHEMBL1631022 0.86 JAK2 (0.54) TNIKJAK2JAK1TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed